π
Hot Stocks
Read Alert β
Eli Lilly Sets Early 2027 Filing Date for Retatrutide After Two More Successful Trials
Eli Lilly announced this week that it plans to submit retatrutide, its next-generation obesity treatment, for regulatory approval during theβ¦
Read Alert β